These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 27789529)

  • 1. Molecular Pathways: The eIF4F Translation Initiation Complex-New Opportunities for Cancer Treatment.
    Malka-Mahieu H; Newman M; Désaubry L; Robert C; Vagner S
    Clin Cancer Res; 2017 Jan; 23(1):21-25. PubMed ID: 27789529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the eIF4F translation initiation complex: a critical nexus for cancer development.
    Pelletier J; Graff J; Ruggero D; Sonenberg N
    Cancer Res; 2015 Jan; 75(2):250-63. PubMed ID: 25593033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translational control of cell fate: from integration of environmental signals to breaching anticancer defense.
    Bitterman PB; Polunovsky VA
    Cell Cycle; 2012 Mar; 11(6):1097-107. PubMed ID: 22356766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attacking a nexus of the oncogenic circuitry by reversing aberrant eIF4F-mediated translation.
    Bitterman PB; Polunovsky VA
    Mol Cancer Ther; 2012 May; 11(5):1051-61. PubMed ID: 22572598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquired Tamoxifen Resistance in MCF-7 Breast Cancer Cells Requires Hyperactivation of eIF4F-Mediated Translation.
    Fagan DH; Fettig LM; Avdulov S; Beckwith H; Peterson MS; Ho YY; Wang F; Polunovsky VA; Yee D
    Horm Cancer; 2017 Aug; 8(4):219-229. PubMed ID: 28577281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of eIF4F Translation Initiation Complex by the Peptidyl Prolyl Isomerase FKBP7 in Taxane-resistant Prostate Cancer.
    Garrido MF; Martin NJ; Bertrand M; Gaudin C; Commo F; El Kalaany N; Al Nakouzi N; Fazli L; Del Nery E; Camonis J; Perez F; Lerondel S; Le Pape A; Compagno D; Gleave M; Loriot Y; Désaubry L; Vagner S; Fizazi K; Chauchereau A
    Clin Cancer Res; 2019 Jan; 25(2):710-723. PubMed ID: 30322877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translation initiation complex eIF4F is a therapeutic target for dual mTOR kinase inhibitors in non-Hodgkin lymphoma.
    Demosthenous C; Han JJ; Stenson MJ; Maurer MJ; Wellik LE; Link B; Hege K; Dogan A; Sotomayor E; Witzig T; Gupta M
    Oncotarget; 2015 Apr; 6(11):9488-501. PubMed ID: 25839159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the eIF4F translation initiation complex for cancer therapy.
    Konicek BW; Dumstorf CA; Graff JR
    Cell Cycle; 2008 Aug; 7(16):2466-71. PubMed ID: 18719377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of small molecules targeting eIF4A.
    Naineni SK; Itoua Maïga R; Cencic R; Putnam AA; Amador LA; Rodriguez AD; Jankowsky E; Pelletier J
    RNA; 2020 May; 26(5):541-549. PubMed ID: 32014999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developing anti-neoplastic biotherapeutics against eIF4F.
    Steinberger J; Chu J; Maïga RI; Sleiman K; Pelletier J
    Cell Mol Life Sci; 2017 May; 74(9):1681-1692. PubMed ID: 28004147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the translation machinery in cancer.
    Bhat M; Robichaud N; Hulea L; Sonenberg N; Pelletier J; Topisirovic I
    Nat Rev Drug Discov; 2015 Apr; 14(4):261-78. PubMed ID: 25743081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging therapeutics targeting mRNA translation.
    Malina A; Mills JR; Pelletier J
    Cold Spring Harb Perspect Biol; 2012 Apr; 4(4):a012377. PubMed ID: 22474009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-Myc and eIF4F constitute a feedforward loop that regulates cell growth: implications for anticancer therapy.
    Lin CJ; Malina A; Pelletier J
    Cancer Res; 2009 Oct; 69(19):7491-4. PubMed ID: 19773439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. mTOR signaling: implications for cancer and anticancer therapy.
    Petroulakis E; Mamane Y; Le Bacquer O; Shahbazian D; Sonenberg N
    Br J Cancer; 2006 Jan; 94(2):195-9. PubMed ID: 16404421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K/PTEN/Akt/mTOR pathway.
    Martelli AM; Evangelisti C; Chappell W; Abrams SL; Bäsecke J; Stivala F; Donia M; Fagone P; Nicoletti F; Libra M; Ruvolo V; Ruvolo P; Kempf CR; Steelman LS; McCubrey JA
    Leukemia; 2011 Jul; 25(7):1064-79. PubMed ID: 21436840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor suppression by small molecule inhibitors of translation initiation.
    Chen L; Aktas BH; Wang Y; He X; Sahoo R; Zhang N; Denoyelle S; Kabha E; Yang H; Freedman RY; Supko JG; Chorev M; Wagner G; Halperin JA
    Oncotarget; 2012 Aug; 3(8):869-81. PubMed ID: 22935625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translating from cancer to the brain: regulation of protein synthesis by eIF4F.
    Kats IR; Klann E
    Learn Mem; 2019 Sep; 26(9):332-342. PubMed ID: 31416906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The proteasome inhibitor, MG132, promotes the reprogramming of translation in C2C12 myoblasts and facilitates the association of hsp25 with the eIF4F complex.
    Cowan JL; Morley SJ
    Eur J Biochem; 2004 Sep; 271(17):3596-611. PubMed ID: 15317596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer Plasticity: The Role of mRNA Translation.
    Lee LJ; Papadopoli D; Jewer M; Del Rincon S; Topisirovic I; Lawrence MG; Postovit LM
    Trends Cancer; 2021 Feb; 7(2):134-145. PubMed ID: 33067172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The plasticity of mRNA translation during cancer progression and therapy resistance.
    Fabbri L; Chakraborty A; Robert C; Vagner S
    Nat Rev Cancer; 2021 Sep; 21(9):558-577. PubMed ID: 34341537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.